HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 23.493 ↓ -0.28%
[as on 13 November, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 40 SMA
  • 500 SMA

Returns

CAGR returns till date

CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan and its peers as on 13 November, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 33.08% -0.28% 2.97% 9.28% 5.99% 31.6% 31.28%---
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -9.29% -0.27% 0.2% 3.18% -6.26% -10.5% 4.93% 8.92% 13.82% 14.25%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth 0.75% -0.5% 1.2% 9.63% 2.07% 1.58% 11.19% 7.88% 12.9% 12.67%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 29.68% -0.01% 3.26% 10.03% 4.42% 26.07% 25.42% 20.65% 26.17% 15.92%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 3.39% -0.04% 1.28% 6.76% -0.65% 3.49% 12.47% 14.96% 19.21% 15.81%
SBI COMMA Fund - DIRECT PLAN - Growth 4.37% -0.55% 0.42% 4.29% -2.46% 6.57% 14.27% 9.88% 18.09% 14.96%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 52.37% 1.73%

Discrete returns (monthly)

MonthJan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026Oct 2026
Returns -4.65% 6.99% -4.36% 7.84% 5.11% 6.59% 3.59% 3.8% -2.11% 0.33%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 18.96%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.42% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.58%

Equity

NameSymbol / ISINSectorWeight %Other links
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology9.54%
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology8.94%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology4.08%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services4.06%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology4.04%
Cipla Ltd.CIPLA (INE059A01026)Pharmaceuticals & Biotechnology3.94%
Aster DM Quality Care LimitedASTERDM (INE914M01019)Healthcare Services3.84%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology3.70%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology3.48%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology3.24%
Ipca Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology3.23%
Shilpa Medicare LtdSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology3.10%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology3.06%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services2.85%
Rubicon Research LimitedRUBICON (INE506V01022)Pharmaceuticals & Biotechnology2.82%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services2.37%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology2.34%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services2.25%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.24%
Jupiter Life Line Hospitals Limited (INE682M01020)Healthcare Services1.94%
Zydus Lifesciences LimitedZYDUSLIFE (INE010B01027)Pharmaceuticals & Biotechnology1.93%
Dr Reddys Laboratories Ltd.DRREDDY (INE089A01031)Pharmaceuticals & Biotechnology1.90%
Metropolis Healthcare Ltd.METROPOLIS (INE112L01020)Healthcare Services1.90%
Molbio Diagnostics Limited (INE869T01028)Healthcare Equipment & Supplies1.77%
Biocon Ltd.BIOCON (INE376G01013)Pharmaceuticals & Biotechnology1.73%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.61%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology1.60%
Apollo Hospitals Enterprise Ltd.APOLLOHOSP (INE437A01024)Healthcare Services1.39%
Thyrocare Technologies Ltd.THYROCARE (INE594H01019)Healthcare Services1.31%
SYMBIOTEC PHARMALAB LIMITED**** (INE899I01028)Pharmaceuticals & Biotechnology1.21%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology1.18%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.09%
CORONA REMEDIES LIMITEDCORONA (INE02ZQ01018)Pharmaceuticals & Biotechnology1.07%
Eris Lifesciences LtdERIS (INE406M01024)Pharmaceuticals & Biotechnology1.06%
Jubilant Pharmova LimitedJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology0.85%
BAJAJ HEALTHCARE LIMITEDBAJAJHCARE (INE411U01027)Pharmaceuticals & Biotechnology0.57%
Novartis India Ltd.NOVARTIND (INE234A01025)Pharmaceuticals & Biotechnology0.47%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies0.38%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology0.34%
Portfolio data is as on date 31 August, 2026

NAV history

HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history

DateNAV% change
13 November, 202623.493 -0.28%
12 November, 202623.56 0.6%
11 November, 202623.42 -0.2%
9 November, 202623.467 2.86%
6 November, 202622.815 0.89%
5 November, 202622.614 0.58%
4 November, 202622.484 1.07%
3 November, 202622.246 0.88%
2 November, 202622.052 0.46%
30 October, 202621.952 0.41%
29 October, 202621.862 0.68%
28 October, 202621.715 1.02%
27 October, 202621.496 2.17%
26 October, 202621.039 1.85%
23 October, 202620.656 -0.68%
22 October, 202620.797 -0.11%
21 October, 202620.819 -0.65%
19 October, 202620.956 -1.29%
16 October, 202621.23 0.03%
15 October, 202621.224 -0.24%
14 October, 202621.275 -1.04%
13 October, 202621.498 -0.16%
12 October, 202621.532 -0.13%
9 October, 202621.561 0.77%
8 October, 202621.396 -2.37%
7 October, 202621.916 -0.33%
6 October, 202621.988 0.97%
5 October, 202621.777 -0.92%
1 October, 202621.979 0.16%
30 September, 202621.944

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 23.493 as on 13 November, 2026.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 33.08% as on 13 November, 2026.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 31.6% as on 13 November, 2026.
  • What are 3 year CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The 3 year annualized returns (CAGR) of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 31.28% as on 13 November, 2026.
  • What are top 10 holdings of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    Top 10 holdings of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are:
    • Divis Laboratories Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Torrent Pharmaceuticals Ltd.
    • Max Healthcare Institute Limited
    • Lupin Ltd.
    • Cipla Ltd.
    • Aster DM Quality Care Limited
    • Neuland Laboratories Limited
    • Anthem Biosciences Limited
    • Acutaas Chemicals Limited
    • Ipca Laboratories Ltd.
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.